Search research articles
Contact Us
Filters
Showing results (41-50 of 57) with videos related to
Page
of 6
Sort By:
Nature Medicine
|
November 14, 2018
Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia
Daniel A Pollyea, Brett M Stevens, Courtney L Jones, et al.
The Journal of Biological Chemistry
|
August 31, 2016
Rational Design of a Parthenolide-based Drug Regimen That Selectively Eradicates Acute Myelogenous Leukemia Stem Cells
Shanshan Pei, Mohammad Minhajuddin, Angelo D'Alessandro, et al.
Cancer Discovery
|
October 8, 2020
The Hepatic Microenvironment Uniquely Protects Leukemia Cells through Induction of Growth and Survival Pathways Mediated by LIPG
Haobin Ye, Mohammad Minhajuddin, Anna Krug, et al.
Cell Reports. Medicine
|
May 27, 2025
CD97-directed CAR-T cells with enhanced persistence eradicate acute myeloid leukemia in diverse xenograft models
Kai Shang, Deyu Huang, Jun Liu, et al.
Nature
|
May 30, 2014
The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidation
Hiba Ahmad Zahreddine, Biljana Culjkovic-Kraljacic, Sarit Assouline, et al.
JCO Clinical Cancer Informatics
|
October 4, 2022
Machine Learning-Based Exploratory Clinical Decision Support for Newly Diagnosed Patients With Acute Myeloid Leukemia Treated With 7 + 3 Type Chemotherapy or Venetoclax/Azacitidine
Nazmul Islam, Jamie S Reuben, Justin Dale, et al.
Cell Stem Cell
|
June 19, 2018
AMPK/FIS1-Mediated Mitophagy Is Required for Self-Renewal of Human AML Stem Cells
Shanshan Pei, Mohammad Minhajuddin, Biniam Adane, et al.
Haematologica
|
April 13, 2023
Higher-dose venetoclax with measurable residual disease-guided azacitidine discontinuation in newly diagnosed acute myeloid leukemia
Jonathan A Gutman, Amanda Winters, Andrew Kent, et al.
Haematologica
|
June 27, 2024
Lysosomal acid lipase A modulates leukemia stem cell response to venetoclax/tyrosine kinase inhibitor combination therapy in blast phase chronic myeloid leukemia
Mohd Minhajuddin, Amanda Winters, Haobin Ye, et al.
Cell Reports
|
April 4, 2019
The Hematopoietic Oxidase NOX2 Regulates Self-Renewal of Leukemic Stem Cells
Biniam Adane, Haobin Ye, Nabilah Khan, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 57) with videos related to
Sort By:
Page
of 6
Nature Medicine
|
November 14, 2018
Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia
Daniel A Pollyea, Brett M Stevens, Courtney L Jones, et al.
The Journal of Biological Chemistry
|
August 31, 2016
Rational Design of a Parthenolide-based Drug Regimen That Selectively Eradicates Acute Myelogenous Leukemia Stem Cells
Shanshan Pei, Mohammad Minhajuddin, Angelo D'Alessandro, et al.
Cancer Discovery
|
October 8, 2020
The Hepatic Microenvironment Uniquely Protects Leukemia Cells through Induction of Growth and Survival Pathways Mediated by LIPG
Haobin Ye, Mohammad Minhajuddin, Anna Krug, et al.
Cell Reports. Medicine
|
May 27, 2025
CD97-directed CAR-T cells with enhanced persistence eradicate acute myeloid leukemia in diverse xenograft models
Kai Shang, Deyu Huang, Jun Liu, et al.
Nature
|
May 30, 2014
The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidation
Hiba Ahmad Zahreddine, Biljana Culjkovic-Kraljacic, Sarit Assouline, et al.
JCO Clinical Cancer Informatics
|
October 4, 2022
Machine Learning-Based Exploratory Clinical Decision Support for Newly Diagnosed Patients With Acute Myeloid Leukemia Treated With 7 + 3 Type Chemotherapy or Venetoclax/Azacitidine
Nazmul Islam, Jamie S Reuben, Justin Dale, et al.
Cell Stem Cell
|
June 19, 2018
AMPK/FIS1-Mediated Mitophagy Is Required for Self-Renewal of Human AML Stem Cells
Shanshan Pei, Mohammad Minhajuddin, Biniam Adane, et al.
Haematologica
|
April 13, 2023
Higher-dose venetoclax with measurable residual disease-guided azacitidine discontinuation in newly diagnosed acute myeloid leukemia
Jonathan A Gutman, Amanda Winters, Andrew Kent, et al.
Haematologica
|
June 27, 2024
Lysosomal acid lipase A modulates leukemia stem cell response to venetoclax/tyrosine kinase inhibitor combination therapy in blast phase chronic myeloid leukemia
Mohd Minhajuddin, Amanda Winters, Haobin Ye, et al.
Cell Reports
|
April 4, 2019
The Hematopoietic Oxidase NOX2 Regulates Self-Renewal of Leukemic Stem Cells
Biniam Adane, Haobin Ye, Nabilah Khan, et al.
Page
of 6